Roivant Sciences Ltd. · NASDAQ:ROIV

Epperly Melissa B, sold 4,938 Roivant Sciences Ltd. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 17, 2026

On Sep 15, 2026, Epperly Melissa B, (Director) sold 4,938 Roivant Sciences Ltd. shares at an average US$39.74 for US$196K under a trading plan, leaving 9,900 shares. Filed Sep 17, 2026 (Form 4).

Sold
4,938 shares
Price
US$39.74 average (US$39.65 to US$40.38)
Value
US$196K
Holding after
9,900 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common SharesSale4,338US$39.6510,500Direct
Sep 15, 2026Common SharesSale600US$40.389,900Direct

Source

View original at SEC

Related